Suspended PHASE2 INTERVENTIONAL 2-arm NCT00820586

Intramyocardial Delivery of Autologous Bone Marrow

Sponsor: IRCCS San Raffaele

Interventions Mononuclear bone marrow derived cells

Updated 5 times since 2017 Last updated: Feb 1, 2012 Started: May 31, 2007 Primary completion: Jan 31, 2011 Completion: Dec 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Suspended

No more funding support for additional procedures

Listed as NCT00820586, this PHASE2 trial focuses on Refractory Angina and remains suspended. Sponsored by IRCCS San Raffaele, it has been updated 5 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Suspended PHASE2
Jul 2024 — Sep 2024 [monthly]

Suspended PHASE2
Jan 2021 — Jul 2024 [monthly]

Suspended PHASE2
Jun 2018 — Jan 2021 [monthly]

Suspended PHASE2
Jan 2017 — Jun 2018 [monthly]

Suspended PHASE2

First recorded

May 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

IRCCS San Raffaele

Data source: IRCCS San Raffaele

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Milan, Italy